BRAF mutations according to baseline characteristics of patients with material available for tissue micro array (TMA) and gene analyses (n = 446).
- Halfdan Sorbye (519250)
- Anca Dragomir (762742)
- Magnus Sundström (576484)
- Per Pfeiffer (427106)
- Ulf Thunberg (762743)
- Monica Bergfors (762744)
- Kristine Aasebø (762745)
- Geir Egil Eide (668115)
- Fredrik Ponten (2172814)
- Camilla Qvortrup (645212)
- Bengt Glimelius (223880)
Publication date
June 2015
DOIAbstract
<p>Metastases/comorbidity = at time of diagnosis of metastatic disease. P-value = exact p-value by Chi-square test. Synchronous disease = within 6 months after initial diagnose. Abbreviations: WBC; White blood cell count, ALP; alkaline phosphatase, UNL; Upper normal limit, PS; performance status.</p><p>BRAF mutations according to baseline characteristics of patients with material available for tissue micro array (TMA) and gene analyses (n = 446).</p
Add to ORKG